Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study.
Paul EmeryGerd R BurmesterEsperanza NaredoLuigi SinigagliaIvan LagunesFranziska KoenigsbauerPhilip Gerard ConaghanPublished in: Annals of the rheumatic diseases (2020)
NCT02198651, EudraCT 2014-001114-26.